- The incidence of melanoma has been rising rapidly in recent years due to habitual exposure to sunlight. Tanning or pigmentation, resulting from the synthesis and dispersion of melanin within skin, is the main physiological defense against photo-induced injuries, including photocarcinogenesis. An understanding of molecular mechanisms involved in the synthesis of melanin is critical in preventing photo-induced injuries and developing effective therapies. Recent advances in culturing human melanocytes from neonatal and adult skins have allowed for rigorous studies examining molecular mechanisms that regulate human melanogenesis. The applicant's laboratory has identified protein kinase (PKC)-B as a key regulator of human melanogenesis. PKC-B was shown to up-regulate the activity of tyrosinase, the rate-limiting enzyme in melanogenesis.
The aim of this proposal, is to characterize the mechanisms through which PKC-B regulates tyrosinase activity. The proposal has the following objectives: (1) Determine if only the B isoform phosphorylates tyrosinase in vitro, then in vivo; (2) determine if phosphorylation leads to an increase in tyrosinase activity; (3) identify phosphorylation site(s) on tyrosinase. In addition, preliminary studies suggest that the cAMP-dependent pathway, previously implicated as the major signaling pathway regulating murine melanogenesis, up-regulates tyrosinase activity by affecting the level of PKC-B. Thus, the final goal of this proposal is to investigate how the cAMP-dependent pathway influences the expression of PKC-B. In order to examine these objectives two cell lines will be used as model systems: cultured human melanocytes from newborn foreskin which are known to express a, b, g, e, z isoforms of PKC, and NP-MM4 human melanoma cells which express all of the above isoforms except PKC-B. To confirm that only PKC-B phosphorylates tyrosinase in vivo, phosphorylation of tyrosinase in NP-MM4 cells permanently transfected with PKC-B cDNA will be compared to that of non-transfected NP-MM4 cells. It is hoped that these studies will reveal a mechanism through which tyrosinase is activated. Furthermore, by examining the influence of the cAMP-dependent pathway on PKC-B, the applicant will begin to understand the role played by the cAMP-dependent pathway in human melanogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA072763-02
Application #
2633948
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Spalholz, Barbara A
Project Start
1997-03-15
Project End
2000-12-31
Budget Start
1998-01-01
Budget End
1998-10-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Boston University
Department
Dermatology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Park, Hee-Young; Wu, Heng; Killoran, Christina E et al. (2004) The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J Cell Sci 117:3659-68
Park, Hee-Young; Lee, Jin; Gonzalez, Salvador et al. (2004) Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J Invest Dermatol 122:159-66
Wu, Heng; Park, Hee-Young (2003) Protein kinase C-beta-mediated complex formation between tyrosinase and TRP-1. Biochem Biophys Res Commun 311:948-53
Park, H Y; Gilchrest, B A (1999) Signaling pathways mediating melanogenesis. Cell Mol Biol (Noisy-le-grand) 45:919-30
Park, H Y; Perez, J M; Laursen, R et al. (1999) Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem 274:16470-8
Ouahes, N; Phillips, T J; Park, H Y (1998) Expression of c-fos and c-Ha-ras proto-oncogenes is induced in human chronic wounds. Dermatol Surg 24:1354-7;discussion 1358
Ao, Y; Park, H Y; Olaizola-Horn, S et al. (1998) Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation. Exp Cell Res 244:117-24